Having successfully developed a number of drugs through to regulatory approval and commercial sales, Pharmaxis (ASX: PXS) is set to…
Promising early study results released today by clinical stage drug development company Pharmaxis (ASX: PXS), should be a reason for…
The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter…
Leading fund manager Karst Peak Capital has secured a significant interest in a little-known Aussie pharmaceuticals research company, following the…
Streamlining operations to focus on the most profitable side of their pharmaceuticals manufacturing business, Pharmaxis (ASX: PXS) has shored up…
In biotech circles, tackling a rare and difficult disease with few patients does not necessarily equate to targeting an unprofitable…